Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer

Gene Therapy

Volumn 7, Issue 1, 2000, Pages 53-60

  Maruyama Tabata, H ^a   Harada, Y ^a   Matsumura, T ^a   Satoh, E ^a   Cui, F ^a   Iwai, M ^a   Kita, M ^a   Hibi, S ^a   Imanishi, J ^a   Sawada, T ^a   Mazda, O ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Episomal vector; Epstein Barr virus based plasmid vector; Ewing's sarcoma; Gene therapy; Herpes simplex virus thymidine kinase; Polyamidoamine dendrimer

Indexed keywords

AMINE; GANCICLOVIR; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL KILLING; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EWING SARCOMA; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 4; SIMPLEXVIRUS;

EID: 0033959448     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301044     Document Type: Article

References (25)

1. Feigner PL, Ringold GM. Cationic liposome-mediated transfection. Nature (Lond) 1989; 373: 387-388.
2. Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem 1996; 7: 703-714.
3. Kukowska-Latallo JF et al. Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA 1996; 93: 4897-4902.
4. Satoh E et al. Efficient gene transduction by Epstein-Barr virus-based vectors coupled with cationic liposome and HVJ-liposome. Biochem Biophys Res Commun 1997; 238: 795-799.
5. Hirai H et al. Use of EBV-based vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms. Biochem Biophys Res Commun 1997; 241: 112-118.
6. Harada Y et al. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer. Cancer Gene Ther (in press).
7. Yates JE, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (Lond) 1985; 313: 812.
8. Mazda O, Satoh E, Yasutomi K, Imanishi J. Extremely efficient gene transduction into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors. J Immunol Meth 1997; 204: 143-151.
9. + cells by transfecting EBV-based episomal vectors. FEBS Lett 1998; 441: 39-42.
10. Atzpodien J et al. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing. Oncology 1988: 45: 437-443.
11. Sommadossi JP et al. Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function. Rev Infect Dis 1988; 10 (Suppl 3): S507-S514.
12. Izuquierdo M et al. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy. Gene Therapy 1996; 3: 491-495.
13. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med 1997; 3: 1354-1361.
14. Klatzmann D et al. Study group on gene therapy of metastatic melanoma. A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase 'suicide' gene therapy for metastatic melanoma. Hum Gene Ther 1998; 9: 2585-2594.
15. Sterman DH et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 1998; 9: 1083-1092.
16. Judde JD, Spangler G, Magrath I, Bhatia K. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia. Hum Gene Ther 1996; 7: 647-653.
17. Evans TJ, Brooks L, Farrell PJ. A strategy for specific targeting of therapeutic agents to tumor cells of virus-associated cancers. Gene Therapy 1997; 4: 264-267.
18. Kenny S, Ge J-Q, Westphal EM, Olsen J. Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectors. Hum Gene Ther 1998; 9: 1131-1141.
19. Tomalia DA, Durst HD. Supramolecular chemistry I-directed synthesis and molecular recognition. Topics Curr Chem 1993; 165: 193.
20. Singh P et al. Starburst dendrimers: enhanced performance and flexibility for immunoassays. Clin Chem 1994; 40: 1845-1849.
21. Bielinska AU et al. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res 1996; 54: 2176-2182.
22. Qin L et al. Efficient transfer of genes into murine cardiac grafts by starburst polyamidoamine dendrimers. Hum Gene Ther 1998; 9: 553-560.
23. Freeman S et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
24. Pope IM, Poston GJ, Kinsella AR. The role of bystander effect in suicide gene therapy. Eur J Cancer 1997; 33: 1005-1016.
25. Sirac-Dilber M, Edvard-Smith CI. Suicide genes and bystander killing: local and distant effects. Gene Therapy 1997; 4: 273-274.